http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007098093-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bef9070c0e4e87b3da7373f44081559a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df929815fe9e14a40cb5b9cb8d50f383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a564206d8584fa7090db18ff067e7125 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3888b1e96a021fd84377e41e29c8fb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86a5366e296982e4bac13609e127beb2 |
| publicationDate | 2007-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2007098093-A2 |
| titleOfInvention | Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma |
| abstract | This invention relates to the polynucleotides and the encoded polypeptides, including novel sequences, of human or non-human primate genes that are amplified in breast and/or other tumor tissues melanoma, as compared to the corresponding normal tissue. The invention also relates to modulators of such polynucleotides and polypeptides, for example, antibodies, that specifically bind to and/or interfere with the activity of this polypeptide, polynucleotide, its fragments, variants, and antagonists. The invention further relates to compositions containing such a polypeptide, polynucleotide, or modulators thereof and uses of such compositions in methods of treating or preventing cancer, by detecting this polynucleotide, polypeptide, or antibodies thereto in patient samples. The invention also provides diagnostic tests for breast cancer and melanoma, by identifying polypeptides and polynucleotides encoded by the cDNA sequence of the invention that correlate with those disorders. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102725416-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9150642-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012100147-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2449126-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2449126-A1 |
| priorityDate | 2006-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 566.